Tuesday, April 22, 2025 3:01:25 PM
UK Parliament House of Commons will meet on Wednesday 4/23/2025.
Sarah Owens is a Member of Parliament. Ms. Owens will ask 2 questions about NWBio DCVax-L.
The agenda for this meeting, and the list of questions was published today. Ms. Owens is going to ask the UK Secretary of State for Health and Social Care:
(1) when he expects the MHRA to make public their decision on approving & licensing DCVax-L,
(2) does the Secretary plan to work with NICE to expedite market access to DCVax-L, via the NHS?
I certainly hope there is something interesting to glean from the response to this line of questioning.
That being said, I have a very strong feeling it will read wildly similar to the boiler plate responses we’ve already received from the MHRA about this. With a bit more personal compassion caked on.
Working, in concert with the company, very hard to advance this application. We are particularly interested in this application. Very exciting. Going just as fast as we can. We’ll update just as soon as we can. We hope it will be very soon. Etc etc.
Can almost guarantee there will be no comment on the NICE appraisal. Something along the lines of not sure where it is at in the process, but every effort will be made to advance it as fast as possible.
I can also guarantee the folks here will be able to pick apart whatever is said and use it as proof positive that approval is coming next week. If this guy says “we expect a decision sometime in June” there will be people here saying “he would never say that if he actually thought June because then he would get in trouble if it’s later than that. Saying June probably means he thinks it will be done in May, which means we could get news any day now”.
Gonna be fun reading in the morning.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
